Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer

World News: . []

SHANGHAI China and SAN FRANCISCO June 12 2019 GLOBE LINK  -- Zai Lab Limited NASDAQ ZLAB a Shanghai-based innovative commercial stage biopharmaceutical LINK  today announced its approval to commercialize LINK  niraparib an oral once-d...

More news and information about Zai Lab Limited

Published By:

Globe Newswire: 14:23 GMT Wednesday 12th June 2019

Published: .

Search for other references to "announces" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us